Publication | Closed Access
995 INTERIM RESULTS FROM HCV SPRINT-1: RVR/EVR FROM PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRONTM (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHC
45
Citations
0
References
2008
Year
Viral PersistenceViral HepatitisAntiviral TherapyHepatitisVirologyPeginterferon Alfa-2bAntiviral DrugMedicineEpidemiologyCovid-19
No additional data available for this publication yet. Check back later!